These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25917138)

  • 21. Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial.
    Hirst Y; Kerrison R; Kobayashi LC; Counsell N; Djedovic N; Ruwende J; Stewart M; von Wagner C
    BMC Public Health; 2016 Jan; 16():74. PubMed ID: 26809344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing.
    von Wagner C; Cadar D; Hackett RA; Demakakos P; Beeken RJ; Cooper Bailey S; Wolf M; Steptoe A; Renzi C; Stoffel ST
    J Med Screen; 2020 Mar; 27(1):25-30. PubMed ID: 31547753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A lack of information engagement among colorectal cancer screening non-attenders: cross-sectional survey.
    Kobayashi LC; Waller J; von Wagner C; Wardle J
    BMC Public Health; 2016 Jul; 16():659. PubMed ID: 27473593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care.
    Liss DT; Baker DW
    Am J Prev Med; 2014 Mar; 46(3):228-36. PubMed ID: 24512861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in socioeconomic inequalities in cervical, breast, and colorectal cancer screening participation among women in Japan, 2010-2019.
    Ishii K; Tabuchi T; Iso H
    Cancer Epidemiol; 2023 Jun; 84():102353. PubMed ID: 36989957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are anxiety levels associated with the decision to participate in a Swedish colorectal cancer screening programme? A nationwide cross-sectional study.
    Wangmar J; von Vogelsang AC; Hultcrantz R; Fritzell K; Wengström Y; Jervaeus A
    BMJ Open; 2018 Dec; 8(12):e025109. PubMed ID: 30580275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
    Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
    Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-perceived Mental Health Status and Uptake of Fecal Occult Blood Test for Colorectal Cancer Screening in Canada: A Cross-Sectional Study.
    Hategekimana C; Karamouzian M
    Int J Health Policy Manag; 2016 Feb; 5(6):365-71. PubMed ID: 27285514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer fatalism and poor self-rated health mediate the association between socioeconomic status and uptake of colorectal cancer screening in England.
    Miles A; Rainbow S; von Wagner C
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2132-40. PubMed ID: 21953115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Socioeconomic position and participation in colorectal cancer screening.
    Frederiksen BL; Jørgensen T; Brasso K; Holten I; Osler M
    Br J Cancer; 2010 Nov; 103(10):1496-501. PubMed ID: 20959827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Socioeconomic Inequalities in Stomach Cancer Screening in Korea, 2005-2015: After the Introduction of the National Cancer Screening Program.
    Lee EY; Lee YY; Suh M; Choi E; Mai TTX; Cho H; Park B; Jun JK; Kim Y; Oh JK; Ki M; Choi KS
    Yonsei Med J; 2018 Oct; 59(8):923-929. PubMed ID: 30187698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using physician-linked mailed invitations in an organised colorectal cancer screening programme: effectiveness and factors associated with response.
    Tinmouth J; Baxter NN; Paszat LF; Rabeneck L; Sutradhar R; Yun L
    BMJ Open; 2014 Mar; 4(3):e004494. PubMed ID: 24622950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of socioeconomic deprivation on the uptake of colorectal cancer screening in London.
    Lal N; Singh HK; Majeed A; Pawa N
    J Med Screen; 2021 Jun; 28(2):114-121. PubMed ID: 32295488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of colorectal cancer screening across sociodemographic groups in Denmark: a register-based study.
    Pallesen AVJ; Herrstedt J; Westendorp RGJ; Mortensen LH; Kristiansen M
    Acta Oncol; 2021 Mar; 60(3):323-332. PubMed ID: 33427545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: a population-based survey of screening-age women in Great Britain.
    Lo SH; Waller J; Wardle J; von Wagner C
    J Med Screen; 2013 Jun; 20(2):73-9. PubMed ID: 23761420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.
    Symonds EL; Cock C; Meng R; Cole SR; Fraser RJL; Young GP
    Eur J Cancer Prev; 2018 Sep; 27(5):425-432. PubMed ID: 28368949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.